131 related articles for article (PubMed ID: 10750216)
1. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
Craig-McFeely PM; Freemantle SL; Pearce GL; Shakir SA
Br J Gen Pract; 2000 Feb; 50(451):148. PubMed ID: 10750216
[No Abstract] [Full Text] [Related]
2. Prolonged QTc time and ventricular arrhythmia with fexofenadine.
Kashyap AS; Kashyap S
Am J Cardiol; 1999 Nov; 84(10):1278-9. PubMed ID: 10569349
[No Abstract] [Full Text] [Related]
3. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
Pinto YM; van Gelder IC; Heeringa M; Crijns HJ
Lancet; 1999 Mar; 353(9157):980. PubMed ID: 10459910
[No Abstract] [Full Text] [Related]
4. QT lengthening and arrhythmias associated with fexofenadine.
Giraud T
Lancet; 1999 Jun; 353(9169):2072-3. PubMed ID: 10376646
[No Abstract] [Full Text] [Related]
5. Severe cardiac arrhythmia on fexofenadine?
Prescrire Int; 2000 Feb; 9(45):212. PubMed ID: 11503802
[TBL] [Abstract][Full Text] [Related]
6. Fexofenadine and prolonged QT intervals.
Shuster J
Nursing; 1999 Sep; 29(9):72. PubMed ID: 10540625
[No Abstract] [Full Text] [Related]
7. [Drug side effects and their prevention].
Hautarzt; 1997 Aug; 48(8 Suppl):3-4. PubMed ID: 9378645
[No Abstract] [Full Text] [Related]
8. Drug interactions associated with terfenadine and related nonsedating antihistamines.
Zechnich AD; Haxby DG
West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212
[No Abstract] [Full Text] [Related]
9. Causality assessment of adverse drug effects: when is rechallenge ethically acceptable?
Po AL; Kendall MJ
Lancet; 1999 Aug; 354(9179):683. PubMed ID: 10466699
[No Abstract] [Full Text] [Related]
10. Fexofenadine-induced QT prolongation: a myth or fact?
Dhar S; Hazra PK; Malakar S; Mistri G
Br J Dermatol; 2000 Jun; 142(6):1260-1. PubMed ID: 10848773
[No Abstract] [Full Text] [Related]
11. Pustular exacerbation of psoriasis due to fexofenadine.
Saraswat A; Saraswat M
Clin Exp Dermatol; 2006 May; 31(3):477-8. PubMed ID: 16681618
[No Abstract] [Full Text] [Related]
12. [Fexofenadine--progress in antihistamine therapy].
Merk HF
Hautarzt; 1997 Aug; 48(8 Suppl):8. PubMed ID: 9378648
[No Abstract] [Full Text] [Related]
13. [Fexofenadine: a antihistaminic. Review of its practical characteristics].
Caballero E; Ocaña I; Azanza JR; Sádaba B
Rev Med Univ Navarra; 1999; 43(2):93-7. PubMed ID: 11256010
[No Abstract] [Full Text] [Related]
14. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
Shaikh WA
J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
[TBL] [Abstract][Full Text] [Related]
15. Terfenadine and SSRIs.
Tafler G
CMAJ; 1997 Oct; 157(8):1019. PubMed ID: 9347771
[No Abstract] [Full Text] [Related]
16. Antihistamines and the heart.
Marquardt D
West J Med; 1993 Jun; 158(6):613-4. PubMed ID: 8101675
[No Abstract] [Full Text] [Related]
17. Lack of association between fexofenadine and rhabdomyolysis.
Adesanya H
Am J Health Syst Pharm; 2004 Apr; 61(7):724-5; author reply 725. PubMed ID: 15119580
[No Abstract] [Full Text] [Related]
18. Dangers of non-sedating antihistamines.
Clark S
Lancet; 1997 May; 349(9061):1268. PubMed ID: 9142059
[No Abstract] [Full Text] [Related]
19. Is my antihistamine safe?
Ashworth L
Home Care Provid; 1997 Jun; 2(3):117-20. PubMed ID: 9274181
[TBL] [Abstract][Full Text] [Related]
20. Dangers of non-sedating antihistamines.
Himmel MH; Honig PK; Worobec AS
Lancet; 1997 Jul; 350(9070):69; author reply 69-70. PubMed ID: 9217741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
